Press release
September 3, 2026
Cartesian Therapeutics to Participate in Upcoming Investor Conferences
Cartesian Therapeutics, Inc. (RNAC)
FREDERICK, Md., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a late clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced that its management expects to participate in the following investor